Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

November 2023 | 25 pages | ID: N90A98C45BAEN
MarketLine

Abstracts

Noven Pharmaceuticals, Inc. %li%Strategy, SWOT and Corporate Finance Report

Summary

Noven Pharmaceuticals, Inc. %li%Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Noven Pharmaceuticals, Inc. (Noven or 'the company'), a subsidiary of Hisamitsu Pharmaceutical Co Inc, develops and sells prescription pharmaceutical products. These products are marketed under Secuado, Minivelle, Combipatch, and Daytrana brands. The company’s products treat various ailments including Central nervous system disorders vasomotor symptoms associated with menopause hot flashes, and vaginal dryness. It also provides treatment for attention-deficit/hyperactivity disorder in children, depressive disorder, generalized anxiety disorder, panic disorder, and obsessive compulsive disorder. Noven maintains state-of-the art, FDA-approved transdermal manufacturing facilities in Miami, the US. The company is headquartered in Miami, Florida, the US.

Scope

• Detailed information on Noven Pharmaceuticals, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Noven Pharmaceuticals, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Noven Pharmaceuticals, Inc. including a breakdown and examination of key business segments
• Intelligence on Noven Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Noven Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Noven Pharmaceuticals, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Noven Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Noven Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Noven Pharmaceuticals, Inc.: Company Overview
Noven Pharmaceuticals, Inc.: Overview and Key Facts
Noven Pharmaceuticals, Inc.: Overview
Noven Pharmaceuticals, Inc.: Key Facts
Noven Pharmaceuticals, Inc.: Key Employees
Noven Pharmaceuticals, Inc.: Key Employee Biographies
Noven Pharmaceuticals, Inc.: Major Products and Services
Noven Pharmaceuticals, Inc.: Management Statement
Noven Pharmaceuticals, Inc.: Key Competitors
Noven Pharmaceuticals, Inc.: Company Analysis
Noven Pharmaceuticals, Inc.: Business Description
Noven Pharmaceuticals, Inc.: SWOT Analysis
Noven Pharmaceuticals, Inc.: SWOT Overview
Noven Pharmaceuticals, Inc.: Strengths
Noven Pharmaceuticals, Inc.: Weaknesses
Noven Pharmaceuticals, Inc.: Opportunities
Noven Pharmaceuticals, Inc.: Threats
Noven Pharmaceuticals, Inc.: Recent Developments
Noven Pharmaceuticals, Inc.: News and Events Summary
Noven Pharmaceuticals, Inc.: Corporate Governance
Noven Pharmaceuticals, Inc.: Regulatory and Legal Events
Noven Pharmaceuticals, Inc.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Noven Pharmaceuticals, Inc.: Key Facts
Table 2: Noven Pharmaceuticals, Inc.: Key Employees
Table 3: Noven Pharmaceuticals, Inc.: Key Competitors
Table 4: Noven Pharmaceuticals, Inc.: News and Events Summary
Table 5: Noven Pharmaceuticals, Inc.: Corporate Governance
Table 6: Noven Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 7: Noven Pharmaceuticals, Inc.: Research & Development